Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_assertion type Assertion NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_head.
- NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_assertion description "[Although the frequency of mutations in the p16/CDKN2 gene has been detected in approximately 30% of non-small cell lung cancer, loss of heterozygosity on 9p has been observed in greater than 70% of non-small cell lung cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_provenance.
- NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_assertion evidence source_evidence_literature NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_provenance.
- NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_assertion SIO_000772 8988029 NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_provenance.
- NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_assertion wasDerivedFrom befree-20150227 NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_provenance.
- NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_assertion wasGeneratedBy ECO_0000203 NP300885.RAYIxQIR-K0D6lh-2_fvXgztwT09ONbCogCaYRMwlAk5c130_provenance.